![](/img/cover-not-exists.png)
Novel HER2-Targeting antibody-drug conjugates of trastuzumab beyond T-DM1 in breast cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab duocarmazine (SYD985)
Xu, Zhuyu, Guo, Dandan, Jiang, Zhongliang, Tong, Rongsheng, Jiang, Peidu, Bai, Lan, Chen, Lu, Zhu, Yuxuan, Guo, Chun, Shi, Jiangyou, Yu, DongkeLanguage:
english
Journal:
European Journal of Medicinal Chemistry
DOI:
10.1016/j.ejmech.2019.111682
Date:
September, 2019
File:
PDF, 1.21 MB
english, 2019